Effects of geldanamycin on signaling through activator-protein 1 in hypoxic HT29 human colon adenocarcinoma cells

Cancer Research

Volumn 59, Issue 16, 1999, Pages 3935-3940

  Vasilevskaya, Irina A ^a   O'Dwyer, Peter J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANSAMYCIN DERIVATIVE; GELDANAMYCIN; TRANSCRIPTION FACTOR AP 1;

ADENOCARCINOMA; ARTICLE; CARCINOMA CELL; CATALYSIS; CELL TYPE; COLON ADENOCARCINOMA; COMPLEX FORMATION; ELECTROPHORETIC MOBILITY; GENE DISRUPTION; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRESS; TRANSCRIPTION REGULATION;

ANTIBIOTICS, ANTINEOPLASTIC; BENZOQUINONES; CELL HYPOXIA; HT29 CELLS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LACTAMS, MACROCYCLIC; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PROTEIN KINASES; QUINONES; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1;

EID: 0033566822     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Bush, R. S., Jenkin, R. D., and Allt, W. E. C. Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br. J. Cancer, 37 (Suppl. III): 302-306, 1978.
2. Moulder, J. I., and Rockwell, S. Hypoxic fractions of solid tumors: experimental techniques, methods of analysis and a survey of existing data. Int. J. Radiat. Oncol. Biol. Phys., 10: 695-112, 1984.
3. O'Dwyer, P. J., Yao, K-S., Ford, P., Godwin, A. K., and Clayton, M. Effects of hypoxia upon detoxicating enzyme activity and expression in HT29 colon adenocarcinoma cells. Cancer Res., 54: 3082-3087, 1994.
4. Yao, K-S., Godwin, A. K., Johnson, S., Ozols, R. F., O'Dwyer, P. J., and Hamilton, T. C. Evidence for altered regulation of γ-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines: changes in transcription factor expression and function. Cancer Res., 55:4367-4374, 1995.
5. Yao, K-S., and O'Dwyer, P. J. Involvement of NF-κB in the induction of NAD(P)H: quinone oxidoreductase (DT-diaphorase) by hypoxia, oltipraz and mitomycin C. Biochem. Pharmacol., 49: 275-282, 1995.
6. Karin, M., Liu, Z-G., and Zandi, E. AP-1 function and regulation. Curr. Opin. Cell Biol., 9: 240-246, 1997.
7. Kiefer, F., Tibbles, L. A., Lassam, N., Zanke, B., Iscove, N., and Woodgett, J. R. Novel components of mammalian stress-activated protein kinase cascades. Biochem. Soc. Trans., 25: 491-498, 1997.
8. Robinson, M. J., and Cobb, M. H. Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol., 9: 180-186, 1997.
9. Pratt, W. B. The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase. Annu. Rev. Pharmacol. Toxicol., 37: 297-326, 1997.
10. Schulte, T. W., Blagosklonny, M. V., Ingui, C., and Neckers, L. Disruption of Raf-1-hsp90 molecular complex results in destabilizabon of Raf-1 and loss of Raf-1-Ras association. J. Biol. Chem., 270: 24585-24588, 1995.
11. Hallberg, B., Rayter, S. I., and Downward, J. Interaction of Ras and Raf in intact cells upon extracellular stimulation. J. Biol. Chem., 269: 3913-3916, 1994.
12. Hallberg, B., Stancato, S. I., Silverstein, A. M., Owens-Grillo, J. K., Chow, Y-H., Jove, R., and Pratt, W. B. The hsp90-binding antibiotic geldanamycin decreases Raf levels and epidermal growth factor signaling without disrupting formation of signaling complexes or reducing the specific enzymatic activity of Raf kinase. J. Biol. Chem., 272: 4013-4020, 1997.
13. Pratt, W. B. The hsp90-based chaperone system: involvement in signal transduction from a variety of hormone and growth factor receptors. Proc. Soc. Exp. Biol. Med., 217: 420-434, 1998.
14. Grenert, J. P., Sullivan, W. P., Fadden, P., Haystead, T. A. J., Clark, J., Minaugh, E., Krutzsch, H., Ochel, H. J., Schulte, T. W., Sausville, E., Neckers, L. M., and Toft, D. O. The amino-terminal domain of heat shock protein 90 (hsp90) that binds geldanamycin is an ATP/ADP switch domain that regulates hsp90 conformation. J. Biol. Chem., 272: 23843-23850, 1997.
15. Mimnaugh, E. G., Chavany, C., and Neckers, L. Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosin kinase induced by geldanamycin. J. Biol. Chem., 271: 22796-22801, 1996.
16. Whitesell, L., Sutphin, P., Wen, G. A., Schulte, T., Blagosklonny, M. V., and Neckers, L. Geldanamycin-stimulated destabilization of mutated p53 is mediated by the proteasome in vivo. Oncogene 14: 2809-2816, 1997.
17. Schulte, T. W., Won, G. A., and Neckers, L. M. Geldanamycin-induced destabilization of Raf-1 involves the proteasome. Biochem. Biophys. Res. Comun., 239: 655-659, 1997.
18. Yao, K-S., Xanthoudakis, S., Curran, T., and O'Dwyer, P. J. Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol. Cell. Biol., 14: 5997-6003, 1994.
19. Laderoute, K. R., Calaoagan, J. M., Mendonca, H. L., Ausserer, W. A., Chen, E. Y., Giaccia, A. J., and Sutherland, R. M. Early responses of SiHa human squamous carcinoma cells to hypoxic signals: evidence of parallel activation of NF-κB and AP-1 transcriptional complexes. Int. J. Oncology, 8: 875-882, 1996.
20. Auserer, W. A., Bourrat-Floeck, B., Green, C. J., Laderoute, K. R., and Sutherland, R. M. Regulation of c-jun expression during hypoxic and low glucose stress. Mol. Cell. Biol., 14: 5032-5042, 1994.
21. Muller, J. M., Krauss, B., Kaltschmidt, C., Baeuerle, P. A., and Rupec, R. A. Hypoxia induces c-fos transcription via mitogen-activated protein kinase-dependent pathway. J. Biol. Chem., 272: 23435-23439, 1997.
22. Webster, K. A., Discher, D. J., and Bishorpic, N. H. Induction and nuclear accumulation of fos and jun proto-oncogenes in hypoxic cardiac myocytes. J. Biol. Chem., 268: 16852-16858, 1993.
23. Seko, Y., Tobe, K., Ueki, K., Kadowaki, T., and Yazaki, Y. Hypoxia, and hypoxia/ reoxygenation activate Raf-1, mitogen-activated protein kinase kinase, mitogen-activated protein kinases, and S6 kinase in cultured rat cardiac myocytes. Circ. Res., 78: 82-90, 1996.
24. Seko, Y., Takahashi, N., Tobe, K., Kadowaki, T., and Yazaki, Y. Hypoxia, and hypoxia/reoxygenation activate p65PAK, p38 mitogan-activated protein kinase (MAPK), and stress-activated protein kinase (SAPK) in cultured rat cardiac myocytes. Biochem. Biophys. Res. Comun., 239: 840-844, 1997.
25. Milanini, J., Vinals, F., Pouyssegur, J., and Pages, G. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts. J. Biol. Chem., 273: 18165-18172, 1998.
26. Rozek, D., and Pfeifer, G. P. In vivo protein-DNA interaction at the c-jun promoter: preferred complexes mediate the UV response. Mol. Cell. Biol., 13: 5490-5499, 1993.
27. Van Dam, H., Wilhelm, D., Herr, I., Steffen, A., Herrlih, P., and Angel, P. ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J., 14: 1798-1811, 1991.
28. Morooka, H., Bonventre, J. V., Pombo, C. M., Kyriakis, J. M., and Force, T. Ishemia and reperfusion enhance ATF-2 and c-Jun binding to cAMP response elements and to an AP-1 binding site from c-jun promoter. J. Biol. Chem., 270: 39084-30092, 1995.
29. Schulte, T. W., Blagosklonny, M. V., Romanova, L., Mushinski, J. F., Monia, B. P., Johnston, J. F., Nguyen, P., Trepel, J., and Neckers, L. Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1 -MEK-mitogen-activated protein kinase signalling pathway. Mol. Cel. Biol., 16: 5839-5845, 1996.
30. Yamaki, H., Iguchi-Agira, S. M., and Agira, H. Inhibition of c-myc gene expression in murine lymphoblastome cells by geldanamycin and herbimycin, antibiotics of benzoquinoid ansamycin group. J. Antibiotics, 42: 604-610, 1989.
31. Heruth, D. P., Wetmore, L. A., Leyva, A., and Rothberg, P. G. Influence of protein tyrosine phosphorylation on the expression of the c-myc oncogene in cancer of the large bowel. J. Cell. Biochem., 58: 83-94, 1995.
32. Hartmann, F. Horak, E. M. Cho, C. Lupu, R. Bolen, J. B., Stetler-Stevenson, M. A., Pfreundschuh, M., Waldmann, T. A., and Horak, I. D. Effects of the tyrosine-kinase inhibitor geldanamycin on ligand-induced Her-2/neu activation, receptor expression and proliferation of Her-positive malignant cell lines. Int. J. Cancer, 70: 221-229, 1997.
33. Ochel, H. J., Schulte, T. W., Nguyen, P., Trepel, J., and Neckers, L. The benzoquinone ansamycin geldanamycin stimulates proteolytic degradation of focal adhesion kinase. Mol. Genet. Metab., 66: 24-30, 1999.
34. Whitesell, L., Shifrin, S. D., Schwab, G., and Neckers, L. M. Benzoquinonoid ansamycins possess selective tumoricidal activity unrelated to src kinase inhibition. Cancer Res., 52: 1721-1728, 1992.
35. Fanger, G. R., Gerwins, P., Widmann, C., Jarpe, M. B., and Johnson, G. L. MEKKs, GSKs, PAKs, TAKs, and Tpls: upstream regulators of the c-Jun amino-terminal kinases? Curr. Opin. Genet. Dev., 7: 67-74, 1997.
36. Dasgupta, G., and Momand, J. Geldanamycin prevents nuclear translocation of mutant p53. Exp. Cell Res., 237: 29-37, 1997.
37. Bunn, H. F., and Poyton, R. O. Oxygen sensing and molecular adaptation to hypoxia. Physiol. Rev., 76: 839-885, 1996.
38. Blancher, C., and Harris, A. L. The molecular basis of the hypoxia response pathway: tumor hypoxia as a therapy target. Cancer Metastasis Rev., 17: 187-194, 1998.
39. Siemeister, G., Baron-Martiny, G., and Marme, D. The pivotal role of VEGF in tumor angiogenesis: molecular facts and therapeutic opportunities. Cancer Metastasis Rev., 17: 241-248, 1998.
40. Damert, A., Ikeda, E., and Risau, W. Activator-protein-1 binding potentiates the hypoxia-inducible factor-1-mediated hypoxia-induced transcriptional activation of vascular endothelial growth factor expression in c6 glioma cells. Biochem. J., 327: 419-423, 1997.
41. Potapova, O., Haghighi, A., Bost, F., Liu, C., Birrer, M. J., Gjerset, R., and Mercola, D. The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin. J. Biol. Chem., 272: 14041-14044, 1997.
42. Schulte, T. W., and Neckers, L. M. The benzoquinone ansamycin 17-allyloamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin. Cancer Chemother. Pharmacol., 42: 273-279, 1998.